1.Ford ES, Ajani UA, Croft JB et al. (2007) Explaining the decrease in US deaths from coronary disease, 1980–2000. N Engl J Med 356, 2388–2398.
2.Rosamond W, Flegal K, Furie K et al. (2008) Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, e25–e146.
3.Clarke R, Collins R, Lewington S et al. (2002) The homocysteine studies collaboration, homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288, 2015–2022.
4.Ford ES, Smith SJ, Stroup DF et al. (2002) Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case–control studies and nested case–control studies. Int J Epidemiol 31, 59–70.
5.Wald NJ, Watt HC, Law MR et al. (1998) Homocysteine and ischaemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 158, 862–867.
6.Clarke R, Frost C, Sherliker P et al. (2005) Homocysteine Lowering Trialists’ Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomised trials. Am J Clin Nutr 82, 806–812.
7.Neal B, MacMahon S, Ohkubo T et al. (2002) Dose-dependent effects of folic acid on plasma homocysteine in a randomised trial conducted among 723 individuals with coronary heart disease. Eur Heart J 23, 1509–1515.
8.Holmquist C, Larsson S, Wolk A et al. (2003) Multivitamin supplements are inversely associated with risk of myocardial infarction in men and women – Stockholm Heart Epidemiology Program (SHEEP). J Nutr 133, 2650–2654.
9.Ishihara J, Iso H, Inoue M et al. (2008) Intake of folate, vitamin B6 and vitamin B12 and the risk of CHD: the Japan Public Health Centre-based Prospective Study Cohort I. J Am Coll Nutr 27, 127–136.
10.Rimm EB, Willett WC, Hu FB et al. (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279, 359–364.
11.Tavani A, Pelucchi C, Parpinel M et al. (2004) Folate and vitamin B(6) intake and risk of acute myocardial infarction in Italy. Eur J Clin Nutr 58, 1266–1272.
12.Schnyder G, Roffi M, Pin R et al. (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345, 1593–1600.
13.Schnyder G, Roffi M, Flammer Y et al. (2002) Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomised controlled trial. JAMA 288, 973–979.
14.Bazzano LA, Reynolds K, Holder KN et al. (2006) Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomised controlled trials. JAMA 296, 2720–2726.
15.Bønaa KH, Njølstad I, Ueland PM et al. (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354, 1578–1588.
16.Ebbing M, Bleie Ø, Ueland PM et al. (2008) Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomised controlled trial. JAMA 300, 795–804.
17.Muntwyler J, Hennekens CH, Manson JE et al. (2002) Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med 162, 1472–1476.
18.Albert CM, Cook NR, Gaziano JM et al. (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomised trial. JAMA 299, 2027–2036.
19.Lonn E, Yusuf S, Arnold MJ et al. (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354, 1567–1577.
20.Yang Q, Botto LD, Erickson JD et al. (2006) Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 113, 1335–1343.
21.Food and Drug Administration (1996) Food standards: amendment of standards of indentity for enriched cereal grain products to require addition of folic acid. Fed Regist 61, 8781–9797.
22.Bazzano LA, He J, Ogden LG et al. (2002) Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey. Stroke 33, 1183–1188.
23.Sepe V, Adamo G, Giuliano MG et al. (2007) Folic acid for stroke prevention – author reply 651. Lancet 370, 651.
24.Virtanen JK, Voutilainen S, Happonen P et al. (2005) Serum homocysteine, folate and risk of stroke: Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. Eur J Cardiovasc Prev Rehabil 12, 369–375.
25.Wang X, Qin X, Demirtas H et al. (2007) Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369, 1876–1882.
26.Radimer K, Bindewald B, Hughes J et al. (2004) Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999–2000. Am J Epidemiol 160, 339–349.
27.Mokdad AH, Stroup DF & Giles WH (2003) Public health surveillance for behavioural risk factors in a changing environment. Recommendations from the Behavioural Risk Factor Surveillance Team. MMWR Recomm Rep 52, 1–12.
28.Nelson DE, Holtzman D, Bolen J et al. (2001) Reliability and validity of measures from the Behavioural Risk Factor Surveillance System (BRFSS). Soc Prev Med 46, Suppl. 1, S3–S42.
29.Nelson DE, Powell-Griner E, Town M et al. (2003) A comparison of national estimates from the National Health Interview Survey and the Behavioural Risk Factor Surveillance System. Am J Public Health 93, 1335–1341.
30.Satia-Abouta J, Patterson RE, King IB et al. (2003) Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. Am J Epidemiol 157, 944–954.
31.Bush TL, Miller SR, Golden AL et al. (1989) Self-report and medical records report agreement of selected medical conditions in the elderly. Am J Public Health 79, 1554–1556.
32.Okura Y, Urban LH, Mahoney DW et al. (2004) Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57, 1096–1103.
33.Satia-Abouta J, Kristal AR, Patterson RE et al. (2003) Dietary supplement use and medical conditions: the VITAL study. Am J Prev Med 24, 43–51.
34.Buettner C, Phillips RS, Davis RB et al. (2007) Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks. Am J Cardiol 99, 661–666.
35.Liem A, Reynierse-Buitenwerf GH, Zwinderman AH et al. (2005) Secondary prevention with folic acid: results of the Goes extension study. Heart 91, 1213–1214.
36.Toole JF, Malinow MR, Chambless LE et al. (2004) Lowering homocysteine in patients with ischaemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomised controlled trial. JAMA 291, 565–575.
37.Moens AL, Vrints CJ, Claeys MJ et al. (2008) Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am J Physiol Heart Circ Physiol 294, H1971–H1977.
38.Fernandez-Miranda C, Yebra M, Aranda JL et al. (2007) Effect of folic acid treatment on carotid intima-media thickness of patients with coronary disease. Int J Cardiol 118, 345–349.
39.Ntaios G, Savopoulos C, Hatzitolios A et al. (2009) Is there a beneficial effect of folic acid on carotid intima-media thickness? Int J Cardiol 135, 260–261.
40.Potter K, Hankey GJ, Green DJ et al. (2008) The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomised controlled trial and meta-analysis. BMC Cardiovasc Disord 8, 24–37.
41.Till U, Rohl P, Jentsch A et al. (2005) Decrease of carotid intima-media thickness in patients at risk to cerebral ischaemia after supplementation with folic acid, vitamins B6 and B12. Atherosclerosis 181, 131–135.
42.Poredos P (2004) Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis. Vasc Med 9, 46–54.
43.Antoniades C, Shirodaria C, Warrick N et al. (2006) 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114, 1193–1201.
44.Nakano E, Higgins JA & Powers HJ (2001) Folate protects against oxidative modification of human LDL. Br J Nutr 86, 637–639.
45.Shirodaria C, Antoniades C, Lee J et al. (2007) Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease. Circulation 115, 2262–2270.
46.Tawakol A, Migrino RQ, Aziz KS et al. (2005) High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease. J Am Coll Cardiol 45, 1580–1584.
47.Doshi SN, McDowell IF, Moat SJ et al. (2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105, 22–26.
48.Setola E, Monti LD, Galluccio E et al. (2004) Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 151, 483–489.
49.Title LM, Ur E, Giddens K et al. (2006) Folic acid improves endothelial dysfunction in type 2 diabetes – an effect independent of homocysteine-lowering. Vasc Med 11, 101–109.
50.Church TS, Earnest CP, Wood KA et al. (2003) Reduction of C-reactive protein levels through use of a multivitamin. Am J Med 115, 702–707.